Skip to content

Medical-device intelligence

DHX: System, Test, Carcinoembryonic Antigen

FDA product code DHX: System, Test, Carcinoembryonic Antigen. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DHX
FDA device name
System, Test, Carcinoembryonic Antigen
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

28 clearance records and 9 recall records in the covered releases, across 27 source company names and 1 product codes. Dated history runs from Sep 26, 1980 to Sep 22, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DHX · System, Test, Carcinoembryonic Antigen289

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

37 matching records
Device / recordCompany in FDA recordSourceSource date
IMMULITE 2000 CARCINOEMBRYONIC ANTIGEN (CEA) KITK980855 · DHXDpc Cirrus510(k)Apr 21, 1998FDA decision date
IMMULITE CEAK970877 · DHXDiagnostic Products Corp.510(k)Sep 22, 1997FDA decision date
AIA-PACK CEA CALIBRATION VERIFICATION TEST SETK924857 · DHXTosoh Medics, Inc.510(k)Mar 18, 1993FDA decision date
TRI-LEVEL LIGAND CONTROLK864877 · DHXCiba Corning Diagnostics Corp.510(k)May 21, 1987FDA decision date
NORMAL GOAT SERUMK833318 · DHXBiosan Laboratories, Inc.510(k)Jan 3, 1984FDA decision date
CARCINOEMBRYONIC ANTIGEN CONTROL (4 LEVK820298 · DHXVentrex Laboratories, Inc.510(k)Apr 8, 1982FDA decision date
CEA CONTROL PLASMAK812658 · DHXPacific Hemostasis510(k)Sep 29, 1981FDA decision date
THREE LEVEL CONTROL SERAK810459 · DHXBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Aug 3, 1981FDA decision date
CEA DESALTING DOLUMN SEPHADEX RK811394 · DHXImmuno-Diagnostic Laboratories510(k)Jun 12, 1981FDA decision date
AMICON ULTRAFILTRATION MEMBRANES CMIIK810810 · DHXAmicon, Inc.510(k)Apr 17, 1981FDA decision date
CARCINOEMBRYONIC ANTIGEN (CEA) CONTROLK792377 · DHXEnvironmental Chemical Specialties510(k)Sep 26, 1980FDA decision date
CLINETICS PCA COLUMNK801306 · DHXClinetics Corp.510(k)Sep 26, 1980FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗